Company
Ahead Together
We unite science, technology and talent to get ahead of disease together.
Scroll to explore
Ahead Together
Getting ahead of disease is one of the most inspiring challenges there is on the planet.We aim to positively impact the health of 2.5 billion people by the end of the decade.
Our leadership team
Find out more about our board and global leadership team who have overall responsibility for delivering our ambition, strategy and culture.
GlaxoSmithKline Pakistan Limited
GSK is a global biopharma company with a purpose to unite science, technology, and talent to get ahead of disease together. In Pakistan, the Company has been providing trusted quality medicines, and vaccines to more than 200 million patients for over seven decades.
Our culture of being ambitious for patients, accountable for impact, and doing the right thing are the foundations for how, together, we’ll deliver for our patients and shareholders, making GSK a company where people can thrive. To achieve this, GSK has built an extensive manufacturing and distribution network, committed to growth and delivering a step change in performance.
GSK Pakistan caters to many therapy areas which include Anti-infectives, Dermatology, Analgesics, and Vaccines. We aim to consistently produce and improve access to quality medicines to make a positive impact on patients’ lives. Our key pharmaceutical brands include Augmentin, Velosef, Amoxil, Dermovate, Clobevate, Betnovate, and Calpol.
GSK holds the position of the largest multinational pharmaceutical company in Pakistan, based on volume, value, and the number of prescriptions generated*. Additionally, among the 700+* pharmaceutical companies operating in the country, both local and multinational, GSK ranks within the top 3 in terms of value and leads in volume. We employ around 1,700 people across our manufacturing, and commercial functions. Our Global Supply Chain (GSC) division, which manufactures over 430 million packs annually, consists of three facilities, all of which are situated in Karachi at F-268 SITE, West Wharf, and Korangi.
GSK F-268 is Pakistan’s largest manufacturing facility situated in Sindh Industrial Trading Estate (SITE), Karachi. This site produces 215 million packs each year from 3 value streams, namely Liquids, Penicillin, and Tablets. Some of the leading brands produced at this site include Augmentin, Amoxil, and Calpol.
Policy positions
We have policies in place across GSK to ensure we meet the high standards we set ourselves as a company, and those that are expected of us externally.
GSK Code of Conduct
Anti-Bribery and Corruption (ABAC) Program
The Anti-Bribery and Corruption (ABAC) Programme is part of GSK’s response to the threat and risk of bribery and corruption. The programme includes an ABAC Policy and Standard, which have been designed to help staff and external parties understand bribery and corruption risk, and their responsibilities to actively combat it.
Third Party Oversight Programme
Our Third Party Oversight Programme helps control risks from third party business engagements with suppliers, distributors and other business partners. We want to work with business partners who share our commitment of high ethical standards and operating in a responsible way.
